Is Aptech overvalued or undervalued?
As of November 7, 2025, Aptech's valuation has improved to attractive, indicating it is undervalued with a PE ratio of 28.48, an EV to EBITDA of 13.60, and a Price to Book Value of 0.26, making it more appealing compared to peers like NIIT Learning and Crizac, despite a year-to-date return of -41.08% against the Sensex's 6.50%.
As of 7 November 2025, the valuation grade for Aptech has moved from fair to attractive, indicating a more favorable assessment of its market position. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE ratio of 28.48, an EV to EBITDA of 13.60, and a Price to Book Value of 0.26, which suggests that the stock is trading at a significant discount relative to its book value.In comparison to peers, Aptech's valuation appears more appealing; for instance, NIIT Learning has a PE ratio of 20.48 and is also rated attractive, while Crizac is deemed very expensive with a PE of 34.44. Despite recent underperformance against the Sensex, with a YTD return of -41.08% compared to the Sensex's 6.50%, the attractive valuation signals potential for recovery and growth in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
